Cancer
Malignant Nasopharyngeal Neoplasm
CI-CAN-00005902Explore in graph →
Top-level261 active trials1 approved drugs
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005902Explore in graph →
Clinical trials
771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (43)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03210389 | A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC. | unknown | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Jul 6, 2017 | clinicaltrials |
| NCT03003182 | A Study of Nasopharyngeal Carcinoma From Guangdong | unknown | — | 2,000 | Sun Yat-sen UniversityOTHER | 1 | Jun 15, 2017 | clinicaltrials |
| Phase IIa Dose-Expansion and Biomarker Study of OPB-111077 |
| unknown |
| Phase 2 |
| 52 |
| National University Hospital, SingaporeOTHER |
| 1 |
| Jun 15, 2017 |
| clinicaltrials |
| NCT03175939 | Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma | completed | Phase 2 | 263 | Sun Yat-sen UniversityOTHER | 0 | Jun 5, 2017 | clinicaltrials |
| NCT03044743 | PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies | unknown | Phase 1 / Phase 2 | 20 | Yang YangOTHER | 1 | May 2, 2017 | clinicaltrials |
| NCT00431210 | Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma | completed | Phase 1 | 28 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT01256385 | Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy(MAESTRO HN) | completed | Phase 2 | 86 | National Cancer Institute (NCI)NIH | 2 | Mar 27, 2017 | clinicaltrials |
| NCT01365208 | New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer | completed | — | 70 | Chinese University of Hong KongOTHER | 1 | Mar 24, 2017 | clinicaltrials |
| NCT03087695 | Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma | unknown | — | 200 | Taichung Veterans General HospitalOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT03068936 | IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma | unknown | Phase 3 | 716 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Mar 3, 2017 | clinicaltrials |
| NCT03058432 | Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 122 | Zhejiang Cancer HospitalOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00797290 | Photon/Proton Radiation Therapy for Carcinoma of the Nasopharynx(NP01) | terminated | — | 9 | University of FloridaOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT03047265 | Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | active not recruiting | Phase 2 | 164 | Sun Yat-sen UniversityOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT03047525 | Study of DC-CTL Combined With CIK for Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 200 | Xiaoyi HuangOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT00516087 | LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)(NATELLA) | completed | Phase 1 | 23 | Baylor College of MedicineOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01370070 | MK-2206 in Recurrent Nasopharyngeal Carcinoma(MC1079) | completed | Phase 2 | 12 | Chinese University of Hong KongOTHER | 1 | Jan 13, 2017 | clinicaltrials |
| NCT02878889 | A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma. | unknown | Phase 2 | 53 | Zhejiang Cancer HospitalOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT03015727 | Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma(IRCNPC) | unknown | Phase 3 | 440 | Zhejiang Cancer HospitalOTHER | 1 | Jan 10, 2017 | clinicaltrials |
| NCT03006588 | EUS-FNA for Retropharyngeal Lymph Node (RPLN) in Recurrent Nasopharyngeal Carcinoma (NPC) Patients | unknown | Phase 2 / Phase 3 | 100 | Sun Yat-sen UniversityOTHER | 1 | Jan 2, 2017 | clinicaltrials |
| NCT02871518 | Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 236 | Sun Yat-sen UniversityOTHER | 1 | Nov 10, 2016 | clinicaltrials |
| NCT00439426 | A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer. | completed | Phase 2 | 25 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01540136 | Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma | completed | Phase 3 | 402 | Sun Yat-sen UniversityOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02944708 | Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 384 | Shanghai Proton and Heavy Ion CenterOTHER | 3 | Oct 27, 2016 | clinicaltrials |
| NCT02421640 | Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC(TIL) | unknown | Phase 2 | 116 | Sun Yat-sen UniversityOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT02907710 | Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 300 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT02854410 | Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients | unknown | N/A | 30 | Capital Medical UniversityOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT02523430 | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma | completed | Phase 1 / Phase 2 | 60 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT02080416 | Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors | terminated | Early Phase 1 | 1 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 10, 2016 | clinicaltrials |
| NCT02786641 | Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 235 | Sun Yat-sen UniversityOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT02610556 | Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma | unknown | Phase 2 | 130 | Sun Yat-sen UniversityOTHER | 1 | May 26, 2016 | clinicaltrials |
| NCT02761291 | Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 1 | 18 | Chang Gung Memorial HospitalOTHER | 1 | May 16, 2016 | clinicaltrials |
| NCT02505672 | Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma | unknown | — | 50 | Rabin Medical CenterOTHER | 1 | Apr 19, 2016 | clinicaltrials |
| NCT02608073 | A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer | completed | Phase 2 | 45 | Hoffmann-La RocheINDUSTRY | 5 | Mar 2, 2016 | clinicaltrials |
| NCT02481089 | Polymorphisms in Key Genes of Glycolytic Pathway: Influence on Radiosensitivity in Nasopharyngeal Carcinoma | unknown | — | 600 | Hunan Province Tumor HospitalOTHER | 1 | Feb 19, 2016 | clinicaltrials |
| NCT00454142 | Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer | completed | Phase 2 | 33 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2015 | clinicaltrials |
| NCT02633176 | Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 120 | Sun Yat-sen UniversityOTHER | 1 | Dec 17, 2015 | clinicaltrials |
| NCT02621970 | Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma | unknown | Phase 3 | 534 | Sun Yat-sen UniversityOTHER | 1 | Dec 4, 2015 | clinicaltrials |
| NCT02610010 | Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma | unknown | Phase 3 | 462 | Sun Yat-sen UniversityOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT02604472 | Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients | completed | — | 12,206 | Sun Yat-sen UniversityOTHER | 0 | Nov 13, 2015 | clinicaltrials |
| NCT01074021 | Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer | unknown | Phase 3 | 480 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Oct 30, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01616849 | Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma | completed | Phase 2 | 39 | Sun Yat-sen UniversityOTHER | 1 | Sep 22, 2015 | clinicaltrials |
| NCT02537925 | The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma | unknown | Phase 3 | 120 | Changjie HuangOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT02293356 | Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma | unknown | Phase 4 | 2,000 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT02199132 | Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli | completed | — | 50 | Corporacion Parc TauliOTHER | 1 | Aug 3, 2015 | clinicaltrials |
| NCT02500940 | Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 54 | Taichung Veterans General HospitalOTHER | 1 | Jul 17, 2015 | clinicaltrials |
| NCT00706316 | Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal Cancer(NPC-CTL) | completed | Phase 1 | 5 | University Health Network, TorontoOTHER | 1 | Jul 10, 2015 | clinicaltrials |
| NCT02058017 | OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy | terminated | Phase 1 | 9 | National University Hospital, SingaporeOTHER | 1 | Jun 19, 2015 | clinicaltrials |
| NCT01694576 | NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation | terminated | Phase 2 | 10 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Jun 15, 2015 | clinicaltrials |
| NCT00458978 | Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer | completed | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Jul 6, 2017source: clinicaltrials